January 21, 2014 | Industry News Release
Source: Healthcare Finance News
Healthcare Supply Chain Association President Curtis Rooney today released the following statement on recent Food and Drug Administration (FDA) guidance on improving the safety of compounded drugs:
“The Healthcare Supply Chain Association and our group purchasing organization (GPO) members applaud Commissioner Hamburg and the FDA for their leadership on improving the safety of compounded drugs and drug compounding facilities.
“HSCA and its members are supply chain leaders in patient safety and product sourcing. We support, as best practice, large commercial compounders of sterile injectable drugs registering with the FDA as outsourcing facilities in order to help maintain proper oversight and to better meet the needs of the patients they serve.
“While compounders are not legally required to register with FDA, HSCA believes that doing so is an important step that will help assure patients and the general public that sound manufacturing practices are being followed.
“Because GPOs do not take title to these drugs, and because we rely on the expertise of FDA’s safety and quality inspections, it is critical to patient safety that FDA has the best tools at its disposal to maintain appropriate oversight of compounding facilities.”
About the Healthcare Supply Chain Association (HSCA)
The Healthcare Supply Chain Association, formerly the Health Industry Group Purchasing Association, is a broad-based trade association that represents 14 group purchasing organizations, including for-profit and not-for-profit corporations, purchasing groups, associations, multi-hospital systems and healthcare provider alliances. HSCA’s mission is to advocate on behalf of healthcare group purchasing associations, to provide educational opportunities designed to improve efficiencies in the purchase, sale and utilization of all goods and services within the health industry and to promote meaningful dialogue between GPOs. For more information, visit www.supplychainassociation.org.
quoted from here
“The Healthcare Supply Chain Association and our group purchasing organization (GPO) members applaud Commissioner Hamburg and the FDA for their leadership on improving the safety of compounded drugs and drug compounding facilities.
“HSCA and its members are supply chain leaders in patient safety and product sourcing. We support, as best practice, large commercial compounders of sterile injectable drugs registering with the FDA as outsourcing facilities in order to help maintain proper oversight and to better meet the needs of the patients they serve.
“While compounders are not legally required to register with FDA, HSCA believes that doing so is an important step that will help assure patients and the general public that sound manufacturing practices are being followed.
“Because GPOs do not take title to these drugs, and because we rely on the expertise of FDA’s safety and quality inspections, it is critical to patient safety that FDA has the best tools at its disposal to maintain appropriate oversight of compounding facilities.”
About the Healthcare Supply Chain Association (HSCA)
The Healthcare Supply Chain Association, formerly the Health Industry Group Purchasing Association, is a broad-based trade association that represents 14 group purchasing organizations, including for-profit and not-for-profit corporations, purchasing groups, associations, multi-hospital systems and healthcare provider alliances. HSCA’s mission is to advocate on behalf of healthcare group purchasing associations, to provide educational opportunities designed to improve efficiencies in the purchase, sale and utilization of all goods and services within the health industry and to promote meaningful dialogue between GPOs. For more information, visit www.supplychainassociation.org.
quoted from here